Experian helps verify the identity of patients and provide secure enrollment to healthcare portals by integrating with major electronic medical records platform
Precise ID(SM) for healthcare portals helps safeguard a patient’s electronic health records within online portals
COSTA MESA, Calif., Dec. 19, 2013 /PRNewswire/ — Experian(®), the leading global information services company, today announced that it has integrated its identity proofing and risk-based authentication platform, Precise ID(SM) for healthcare portals, with Epic’s MyChart patient portal to enable healthcare providers to quickly and securely authenticate, validate and risk-assess patient identities prior to accessing medical information online.
“As more healthcare organizations are providing access to electronic records, hospitals and medical groups will need to further ensure the security and confidentiality of each patient’s information,” said Dan Buell, general manager of Experian Healthcare. “For years, our Precise ID platform has been helping financial organizations and government agencies authenticate users. We are now leveraging this expertise to ease the patient portal enrollment process that in turn can help public and private healthcare providers meet their Meaningful Use Stage 2 requirements, which state that 5 percent of patients must be able to view, download or transmit their health records. The integration of Precise ID for healthcare portals with Epic’s application will instill a level of trust and confidence with patients that their medical and personal information remains secure.”
Precise ID for healthcare portals combines Experian’s state-of-the-art identity proofing and risk-based authentication technology with industry-leading data assets and advanced analytics to help healthcare organizations securely verify each patient’s identity. Prior to accessing medical information online, patients and authorized users can be authenticated via a combination of real-time questions that only they are likely to know.
With this integration, Experian’s Precise ID adds to its growing list of users, including numerous public and private healthcare systems as well as federal, state and local government agencies, to meet identity proofing requirements either in a standalone environment or via a more robust multifactor credentialing program.
About Precise ID and Precise ID for healthcare portals
With Precise ID, healthcare providers have access to a proven authentication and fraud detection service that has been assessed and certified by the Kantara Initiative and meets the industry’s best practice recommendation by the National Institute of Standards and Technology (NIST) of level 3 assurance for identity proofing.
The Precise ID platform offers a flexible framework that enables healthcare providers to incorporate it into their existing identity proofing and authentication processes, allowing connectivity with various electronic health records and patient management systems.
For more information on Precise ID for healthcare portals, or Experian Healthcare’s other leading products and services, visit http://www.experian.com/healthcare.
Experian is the leading global information services company, providing data and analytical tools to clients around the world. The Group helps businesses to manage credit risk, prevent fraud, target marketing offers and automate decision making. Experian also helps individuals to check their credit report and credit score, and protect against identity theft.
Experian plc is listed on the London Stock Exchange (EXPN) and is a constituent of the FTSE 100 index. Total revenue for the year ended March 31, 2013, was US$4.7 billion. Experian employs approximately 17,000 people in 40 countries and has its corporate headquarters in Dublin, Ireland, with operational headquarters in Nottingham, UK; California, US; and São Paulo, Brazil.
For more information, visit http://www.experianplc.com.
Experian and the Experian marks used herein are service marks or registered trademarks of Experian Information Solutions, Inc. Other product and company names mentioned herein are the property of their respective owners.